Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-α and interleukin-1β by peripheral blood monocytes in the acute phase of Kawasaki disease

European Journal of Pediatrics

Volumn 155, Issue 4, 1996, Pages 291-296

  Suzuki, Hiroyuki ^a   Uemura, Shigeru ^a   Tone, Shigenobu ^a   Iizuka, Tadashi ^a   Koike, Michio ^a   Hirayama, Kenji ^a   Maeda, Jiro ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

IL 1 ; Immunoglobulin therapy; Kawasaki disease; Macrophages monocytes; TNF

Indexed keywords

ACETYLSALICYLIC ACID; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; IN VITRO STUDY; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MONOCYTE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0029983074     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02002715     Document Type: Article

References (28)

1. Anderson JP, Anderson UG (1990) Human intravenous immunoglobulin modulates monokine production in vitro. Immunology 71:372-376
2. Andersson UG, Bjork L, Skansen-Saphir U, Andersson JP (1993) Down-regulation of cytokine production and interleukin-2 receptor expression by pooled IgG. Immunology 79:211-216
3. Berkman SA, Lee ML, Gale RP (1990) Clinical use of intravenous immunoglobulins. Ann Intern Med 112:278-292
4. Debets JMH, Van Der Linden CJ, Dieteren IEM, Leeuwenberg JFM, Buurman WA (1988) Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes. J Immunol 141:1197-1201
5. Dwyer JM (1992) Manipulating the immune system with immune globulin. N Engl J Med 326:107-116
6. Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, et al (1988) Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 48:247-251
7. Furusho K, Kamiya T, Nakano H, Kiosawa N, Shinomiya K, Hayashida T, et al (1984) High dose intravenous gammaglobulin for Kawasaki disease. Lancet II:1055-1058
8. Gifford GE, Lohmann-Matthes ML (1987) Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide. J Natl Cancer Inst 78:121-124
9. Harada K, Yamaguchi H, Hase N, Sato T, Asai T, Tatara K, et al (1988) Intravenous gammaglobulin treatment in Kawasaki disease. Presented at the Third International Kawasaki Disease Symposium, Tokyo, Japan, Proceedings, pp 314-317
10. Iizuka T, Minatogawa Y, Suzuki H, Mutsumi Ito, Shigeru Nakamine, Yoshihumi Hatanaka, et al (1993) Urinary neopterin as a predictive marker of coronary artery abnormalities in Kawasaki syndrome. Clin Chem 39: 600-604
11. Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: clinical observation of 50 cases. Jpn J Allergol 16:178-222
12. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H (1974) A new infantile acute febrile mucokutaneous lymph node syndrome(MLNS) prevailing in Japan. Pediatrics 54:271-276
13. Lang BA, Silverman ED, Laxer RM, Lau AS (1989) Spontaneous tumor necrosis factor production in Kawasaki disease. J Pediatr 115:939-943
14. Leung DYM, Cotran RS, Kurt-Jomes E, Burns JC, Newburger JW, Pober JS (1989) Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawsaki disease. Lancet 11:1298-1302
15. Lin C-Y, Lin C-C, Hwang B, Chiang BN (1991) The changes of interleukin-2, tumor necrotic factor and gamma-interferon production among patients with Kawasaki disease. Eur J Pediatr 150:179-182
16. Ling Z-D, Yeoh E, Webb BT, Farrell K, Doucette J, Matheson DS (1993) Intravenous Immunoglobulin induces Interferon- and interleukin-6 in vivo. J Clin Immunol 13:302-309
17. Maury CPJ, Salo E, Pelkonen P (1989) Elevated circulating tumor necrosis factor-α in patients with Kawasaki disease. J Lab Clin Med 113:651-654
18. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, et al (1986) The treatment of Kawasaki syndrome with intravenous gammaglobulin. N Engl J M 315:341-347
19. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al (1991) A single intravenous infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324: 1633-1639
20. Okuni M, Harada K, Yamaguchi H, Yanagawa H, Sonobe T, Kawasaki T (1987) Intravenous Gammaglobulin therapy in Kawasaki disease: trial of low-dose gamma globulin. In: Shulman ST (ed) Kawasaki disease. Alan R Liss, New York, pp 433-439
21. Pål Aukrust, Stig S. Frøland, Nina-Beate Liabakk, Fredrik Müller, Ingvild Nordøy, Charlotte Haug, Terje Espevik (1994) Release of cytokines, soluble cytokine receptors, and interleukine-1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood 84:2136-2143
22. Research Committee on Kawasaki Disease (1984) Report of Subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesion in Kawasaki disease. Tokyo, Japan, Ministry of Health and Welfare, pp 55-66
23. Rosen FS (1993) Putative mechanisms of the effect of intravenous γ-globulin. Clin Immunol Immunopathol 67 [Suppl]:S41-S43
24. Rowley AH, Shulman ST (1991) Current therapy for acute Kawasaki syndrome. J Pediatr 118:987-991
25. Shigenobu Tone, Yuko Katoh, Hirokazu Fujimoto, Shin Togashi, Masako Yanazawa, Yoshihiro Kato, et al (1990) Exression of inhibin a-subunit gene during mouse gametogenesis. Differentiation 44:62-68
26. Shimozato T, Iwata M, Tamura N (1990) Suppression of tumor necrosis factor alpha production by a human immunoglobulin preparation for intravenous use. Infect Immun 58:1384-1390
27. Shulman ST (1989) IVGG therapy in Kawsaki disease: mechanism of action. Clin Immunol Immunopathol 53:141-146
28. Suzuki H, Iizuka T, Uemura S, Koike M, Maeda J (1988) The pathophysiological significance of serum tumor necrosis factor in Kawasaki disease. Presented at the Third International Kawasaki Disease Symposium, Tokyo, Japan, Proceedings, pp 117-119